Making behaviour change stickBehaviour change is set to become a key skill for pharma companies in the very near future – Share XMaking behaviour change stickhttps://pharmaphorum.com/digital/making-behaviour-change-stick/
Does the big pharma monster need taming?Paul Tunnah reviews Hedley Rees’ ‘Taming the Big Pharma Monster: by Speaking Truth to Power’, which takes pharma Share XDoes the big pharma monster need taming?https://pharmaphorum.com/views-analysis-sales-marketing/does-the-big-pharma-monster-need-taming/
The science of prevention‘Prevention’ might be the buzzword of the moment in the pharma industry, but what does it actually mean Share XThe science of preventionhttps://pharmaphorum.com/r-d/views-analysis-r-d/the-science-of-prevention/
Propeller Health: respiring for successDavid Van Sickle is on a mission to transform treatment for respiratory diseases with the company he co-founded, Share XPropeller Health: respiring for successhttps://pharmaphorum.com/r-d/views-analysis-r-d/propeller-health-respiring-for-success/
The real conspiracy in the pharma industryPaul Tunnah on how pharma industry workers can negatively affect patients without even realising it. If you work Share XThe real conspiracy in the pharma industryhttps://pharmaphorum.com/views-and-analysis/the-real-conspiracy-pharma-industry/
Abilify MyCite and innovating in digital healthpharmaphorum’s Paul Tunnah spoke with Otsuka Pharmaceutical’s North America Pharmaceutical Business president and CEO Kabir Nath about the Share XAbilify MyCite and innovating in digital healthhttps://pharmaphorum.com/views-analysis-digital/abilify-mycite-and-innovating-in-digital-health/
Building a new type of pharmaceutical company – a vision for pharma 2.0The definition of healthcare has become incredibly diverse since the turn of the century. It feels like it Share XBuilding a new type of pharmaceutical company – a vision for pharma 2.0https://pharmaphorum.com/views-analysis-sales-marketing/building-new-pharmaceutical-company-pharma-2-0/
Let’s talk about drugsPaul Tunnah asks if we need to rethink pharma’s strict marketing regulations and have a discussion on how Share XLet’s talk about drugshttps://pharmaphorum.com/views-and-analysis/lets-talk-drugs/
JP Morgan Healthcare: where science, tech and finance collideWelcome to 2019! Hopefully by now you’re managing to ease yourself back into things, no doubt with good Share XJP Morgan Healthcare: where science, tech and finance collidehttps://pharmaphorum.com/views-analysis-sales-marketing/jp-morgan-healthcare-science-tech-finance-collide/
